Evaluation of Anticonvulsant Activity of Dual COX-2/5-LOX Inhibitor Darbufelon and Its Novel Analogues

被引:5
|
作者
Mishchenko, Mariia [1 ]
Shtrygol', Sergiy [1 ]
Lozynskyi, Andrii [2 ]
Khomyak, Semen [3 ]
Novikov, Volodymyr [3 ]
Karpenko, Olexandr [4 ]
Holota, Serhii [2 ,5 ]
Lesyk, Roman [2 ,6 ]
机构
[1] Natl Univ Pharm, Dept Pharmacol & Pharmacotherapy, 53 Pushkinska, UA-61002 Kharkiv, Ukraine
[2] Danylo Halytsky Lviv Natl Med Univ, Dept Pharmaceut Organ & Bioorgan Chem, 69 Pekarska, UA-79010 Lvov, Ukraine
[3] Lviv Polytech Natl Univ, Dept Technol Biol Act Subst Pharm & Biotechnol, 12 Bandery, UA-79013 Lvov, Ukraine
[4] Enamine Ltd, 23 Alexandra Matrosova, UA-01103 Kiev, Ukraine
[5] Lesya Ukrainka Volyn Natl Univ, Dept Organ Chem & Pharm, Volya Ave 13, UA-43025 Lutsk, Ukraine
[6] Univ Informat Technol & Management Rzeszow, Dept Publ Hlth Dietet & Lifestyle Disorders, Fac Med, Sucharskiego 2, PL-35225 Rzeszow, Poland
基金
新加坡国家研究基金会;
关键词
4-thiazolidinones; darbufelone; dual COX-2; 5-LOX inhibitor; pentylenetetrazole seizure; anticonvulsant activity; NEUROINFLAMMATION; EPILEPSY; CHALLENGES; RATS; MICE;
D O I
10.3390/scipharm89020022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuroinflammation is an integral part of epilepsy pathogenesis and other convulsive conditions, and non-steroidal anti-inflammatory drugs (NSAIDs) present a potent tool for the contemporary search and design of novel anticonvulsants. In the present paper, evaluation of the anticonvulsant activity of the potential NSAID dual COX-2/5-LOX inhibitor darbufelone methanesulfonate using an scPTZ model in mice in dose 100 mg/kg is reported. Darbufelone possesses anticonvulsant properties in the scPTZ model and presents interest for in-depth studies as a possible anticonvulsant multi-target agent with anti-inflammatory activity. The series of 4-thiazolidinone derivatives have been synthesized following the analogue-based drug design and hybrid-pharmacophore approach using a darbufelone matrix. The synthesized derivatives showed a significant protection level for animals in the scPTZ model and are promising compounds for the design of potential anticonvulsants with satisfactory drug-like parameters.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
    Alessandra Bitto
    Letteria Minutoli
    Antonio David
    Natasha Irrera
    Mariagrazia Rinaldi
    Francesco S. Venuti
    Francesco Squadrito
    Domenica Altavilla
    [J]. Critical Care, 27
  • [32] In vitro COX-1, COX-2 and 5-LOX inhibitory activity of rose hips (Rosae pseudofructus sine fructibus)
    Wenzig, E. M.
    Widowitz, U.
    Kunert, O.
    Bauer, R.
    Chrubasik, S.
    [J]. PLANTA MEDICA, 2007, 73 (09) : 844 - 845
  • [33] Licofelone, A 5-LOX, COX-1 and COX-2 inhibitor, has excellent hepatic tolerability in patients with symptomatic OA of the knee
    Bias, P
    Buchner, A
    Schulz, U
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 366 - 367
  • [34] Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
    Idris, Muhd Hanis Md
    Amin, Siti Norhidayu Mohd
    Amin, Siti Norhidayah Mohd
    Nyokat, Nyotia
    Khong, Heng Yen
    Selvaraj, Manikandan
    Zakaria, Zainul Amiruddin
    Shaameri, Zurina
    Hamzah, Ahmad Sazali
    Teh, Lay Kek
    Salleh, Mohd Zaki
    [J]. BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2022, 11 (01)
  • [35] Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor
    Xu, Guang-Lin
    Liu, Fei
    Ao, Gui-Zhen
    He, Shu-Ying
    Ju, Min
    Zhao, Yue
    Xue, Ting
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 611 (1-3) : 100 - 106
  • [36] Flavonoids as dual inhibitors of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and in vitro studies
    Muhd Hanis Md Idris
    Siti Norhidayu Mohd Amin
    Siti Norhidayah Mohd Amin
    Nyotia Nyokat
    Heng Yen Khong
    Manikandan Selvaraj
    Zainul Amiruddin Zakaria
    Zurina Shaameri
    Ahmad Sazali Hamzah
    Lay Kek Teh
    Mohd Zaki Salleh
    [J]. Beni-Suef University Journal of Basic and Applied Sciences, 11
  • [37] The effects of hcy on the expression of cox-2 and 5-lox in experimental colitis rats model
    Wang, Jing
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 230 - 230
  • [38] Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity
    Saraf, Poorvi
    Tripathi, Prabhash Nath
    Tripathi, Manish Kumar
    Tripathi, Avanish
    Verma, Himanshu
    Waiker, Digambar Kumar
    Singh, Royana
    Shrivastava, Sushant Kumar
    [J]. BIOORGANIC CHEMISTRY, 2022, 129
  • [39] Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): Molecular docking and 3D-QSAR analyses on DHDMBF analogues
    Zheng, MY
    Zhang, ZS
    Zhu, WL
    Liu, H
    Luo, XM
    Chen, KX
    Jiang, HL
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (10) : 3428 - 3437
  • [40] Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2
    Zhang, Bo
    Wang, Chang-Liang
    Zhao, Wen-Hua
    Lv, Ming
    Wang, Chun-Ying
    Zhong, Wei-Xia
    Zhou, Wu-Yuan
    Yu, Wen-Sheng
    Zhang, Yan
    Li, Sheng
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (16) : 2494 - 2500